Acid Sphingomyelinase, Leukocytes
GTR Test Accession: Help GTR000603771.2
METABOLIC DISEASEINHERITED DISEASEIMMUNOLOGY ... View more
Last updated in GTR: 2023-04-07
Last annual review date for the lab: 2024-05-28 LinkOut
At a Glance
Diagnosis
Niemann-Pick disease, type A; Niemann-Pick disease, type B
acid sphingomyelinase
Biochemical Genetics - Enzyme assay: Flow Injection Analysis-Tandem Mass Spectrometry (FIA-MS/MS)
Investigation of possible diagnosis of Niemann-Pick disease types A and …
Not provided
Establish or confirm diagnosis
Ordering Information
Offered by: Help
Test short name: Help
ASMW
Specimen Source: Help
Who can order: Help
  • Genetic Counselor
  • Health Care Provider
  • Licensed Dentist
  • Licensed Physician
  • Nurse Practitioner
  • Physician Assistant
  • Public Health Mandate
  • Registered Nurse
Lab contact: Help
Gisele (Gessi) Bentz Pino, MS, CGC, Certified Genetic counselor, CGC, Genetic Counselor
[email protected]
1-800-533-1710
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order: Help
https://www.mayocliniclabs.com/test-catalog/overview/606264#Specimen
Order URL
Test development: Help
Test developed by laboratory (no manufacturer test name)
Informed consent required: Help
Based on applicable state law
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 2
Condition/Phenotype Identifier
Test Targets
Analytes Help
Total analytes: 1
Analyte Associated Condition
Methodology
Total methods: 1
Method Category Help
Test method Help
Instrument *
Enzyme assay
Flow Injection Analysis-Tandem Mass Spectrometry (FIA-MS/MS)
* Instrument: Not provided
Clinical Information
Test purpose: Help
Diagnosis
Target population: Help
Investigation of possible diagnosis of Niemann-Pick disease types A and B. This test is not recommended for carrier detection because of the wide range of enzymatic activities observed in carriers and noncarriers.
View citations (2)
  • Wasserstein MP, Schuchman EH. Acid Sphingomyelinase Deficiency. 2006 Dec 07 [updated 2023 Apr 27]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. PMID: 20301544.
  • Schuchman EH, Desnick RJ. Types A and B Niemann-Pick disease. Mol Genet Metab. 2017;120(1-2):27-33. doi:10.1016/j.ymgme.2016.12.008. Epub 2016 Dec 16. PMID: 28164782.
Recommended fields not provided:
Technical Information
Test Procedure: Help
The specimens are incubated with a mix of substrate and internal standard for acid sphingomyelinase ,beta-glucocerebrosidase , acid alpha-glucosidase , alpha-galactosidase , galactocerebrosidase and alpha-L-iduronidase . The sample is then purified by liquid-liquid extraction. The extract is evaporated and reconstituted before analysis by tandem mass spectrometry.(Unpublished Mayo method)
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
Accuracy was assessed by analysis of positive and negative specimens; all samples were clinically concordant. Intra assay precision was performed at 3 levels: CV results ranged from 4%-10% (N=20 each). Inter assay precision was performed at 3 levels: CV results ranged from 7%-8% (N=20 each). The analytical measurement range is … View more
Assay limitations: Help
This test can give false-positive acid sphingomyelinase results. OXYBS / Oxysterols, Blood Spot may be ordered as a confirmatory test. Additional biochemical or molecular testing is recommended to confirm a diagnosis if an enzyme deficiency is detected by this screening test.
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Yes

Method used for proficiency testing: Help
Intra-Laboratory

Description of PT method: Help
Intra-laboratory alternative assessment of performance through quality control or patient blind testing

Description of internal test validation method: Help
This test was laboratory developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements.
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Category: FDA exercises enforcement discretion
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.